MED | 合法醫療器材資訊網

2021年1月6日—SAMBA2providesthe“longestlastingbatterylifeofanyactivetranscutaneousaudioprocessoronthemarket,”withapproximately8to10days ...

MED-EL USA[1] announced the launch of the SAMBA 2, a next-generation audio processor for the BONEBRIDGE Bone Conduction System, which includes the recently launched BCI 602. BCI 602 is an active transcutaneous bone conduction implant that leaves skin intact. The BONEBRIDGE System is indicated for individuals age 12 years and older with conductive hearing loss, mixed hearing loss, or single-sided deafness. 

Related article: MED-EL Announces ‘First Surgeries in Europe’ with Totally Implantable Cochlear Implant[2]

The US Food and Drug Administration (FDA)-cleared SAMBA 2 Audio Processor features enhancements for ease of listening and handling, MED-EL says. Intelligent Sound Adapter 2.0 is said to “automatically adjusts settings to match different environments that are particularly challenging to people with hearing loss.” This includes an automatic setting for listening in cars wh...